Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents

被引：0
|
作者：
Yoshiaki Ohtsu
Yoko Susaki
Kiyoshi Noguchi
机构：
[1] Astellas Pharma Inc.,Analysis and Pharmacokinetics Research Laboratories
[2] Astellas Pharma Inc.,Regulatory Management
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2018年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 706
页数：13
相关论文
共 50 条
  • [1] Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents
    Ohtsu, Yoshiaki
    Susaki, Yoko
    Noguchi, Kiyoshi
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 693 - 706
  • [2] Anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor
    Shiraki, Kimiyasu
    Yajima, Misako
    Takemoto, Masaya
    Yoshida, Yoshihiro
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S34 - S35
  • [3] Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor
    Yajima, Misako
    Yamada, Hiroshi
    Takemoto, Masaya
    Daikoku, Tohru
    Yoshida, Yoshihiro
    Long, Tan
    Okuda, Tomoko
    Shiraki, Kimiyasu
    ANTIVIRAL RESEARCH, 2017, 139 : 95 - 101
  • [4] Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir)
    Chono, Koji
    Katsumata, Kiyomitsu
    Kontani, Toru
    Shiraki, Kimiyasu
    Suzuki, Hiroshi
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (04) : 459 - 467
  • [5] Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes
    Katsumata, Kiyomitsu
    Chono, Koji
    Sudo, Kenji
    Shimizu, Yasuaki
    Kontani, Toru
    Suzuki, Hiroshi
    MOLECULES, 2011, 16 (09): : 7210 - 7223
  • [6] Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection
    Katsumata, Kiyomitsu
    Chono, Koji
    Kato, Kota
    Ohtsu, Yoshiaki
    Takakura, Shoji
    Kontani, Toru
    Suzuki, Hiroshi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1339 - 1346
  • [7] Susceptibility of Herpes Simplex Virus Isolated from Genital Herpes Lesions to ASP2151, a Novel Helicase-Primase Inhibitor
    Katsumata, Kiyomitsu
    Weinberg, Adriana
    Chono, Koji
    Takakura, Shoji
    Kontani, Tom
    Suzuki, Hiroshi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3587 - 3591
  • [8] Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model
    Sasaki, Shin-ichi
    Miyazaki, Dai
    Haruki, Tomoko
    Yamamoto, Yukimi
    Kandori, Michiko
    Yakura, Keiko
    Suzuki, Hiroshi
    Inoue, Yoshitsugu
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (04) : 498 - 503
  • [9] Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
    Shiraki, Kimiyasu
    Yasumoto, Shinichiro
    Toyama, Nozomu
    Fukuda, Hiroaki
    VIRUSES-BASEL, 2021, 13 (08):
  • [10] ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2
    Chono, Koji
    Katsumata, Kiyomitsu
    Kontani, Toru
    Kobayashi, Masayuki
    Sudo, Kenji
    Yokota, Tomoyuki
    Konno, Kenji
    Shimizu, Yasuaki
    Suzuki, Hiroshi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (08) : 1733 - 1741
12345